SCHEMBL5757558

SCHEMBL5757558

Cc1ccc(CNc2ccc3ncc(-c4ccccc4)nc3n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 11/20 0.50
MAPK14 Q16539 1/20 0.50
PIK3CA P42336 7/20 0.48
MAPK8 P45983 6/20 0.48
MAPK9 P45984 6/20 0.48
MAPK10 P53779 6/20 0.48
CLK4 Q9HAZ1 2/20 0.48
PRKD3 O94806 1/20 0.46
MAP4K4 O95819 1/20 0.46
POLB P06746 1/20 0.46
PIM1 P11309 1/20 0.46
MARK3 P27448 1/20 0.46
GSK3B P49841 1/20 0.46
PRKAA1 Q13131 1/20 0.46
TAOK1 Q7L7X3 1/20 0.46
PIM3 Q86V86 1/20 0.46
PBK Q96KB5 1/20 0.46
SRPK1 Q96SB4 1/20 0.46
MAP4K5 Q9Y4K4 1/20 0.46
WNT3A P56704 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5759166 0.88 MAPK1 (0.56) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5758049 0.88 MAPK1 (0.48) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5755834 0.88 MAPT (0.49) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5759529 0.87 CYP1A2 (0.51) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5755957 0.85 MAPK1 (0.55) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5757874 0.85 EPHX2 (0.50) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5755117 0.84 MAPK1 (0.51) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5758226 0.83 MAPK1 (0.60) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5760302 0.83 SMN1; SMN2 (0.55) MAPK1MAPK14PIK3CAMAPK8MAPK9
SCHEMBL5757148 0.81 LMNA (0.52) MAPK1MAPK14PIK3CAMAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028729-B1 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ZENTARIS GMBH (DE) 2006-08-16 EP disclosed
US-6727252-B1 THE SERINE/THREONINE KINASE FAMILY INCLUDES MEMBERS THAT REGULATE CELL GROWTH, MIGRATION, DIFFERENTIATION, GENE EXPRESSION, MUSCLE CONTRACTION, GLUCOSE METABOLISM, CELLULAR PROTEIN SYNTHESIS, AND REGULATION OF THE CELL CYCLE ZENTARIS AG (DE) 2004-04-27 US disclosed
US-6180631-B1 PREVENTING AND TREATING SERINE/THREONINE PROTEIN KINASE-RELATED ABNORMAL CONDITIONS IN MAMMALS ASSOCIATED WITH AN ABERRATION IN A SIGNAL TRANSDUCTION PATHWAY SUCH AS CANCER OR A FIBROTIC DISORDER ASTA MEDICA AKTIENGESELLSCHAFT (DE) 2001-01-30 US disclosed
EP-1028729-A2 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ASTA Medica Aktiengesellschaft (DE) 2000-08-23 EP disclosed
WO-1999017759-A2 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed